{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:37:31Z","timestamp":1780511851454,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11033-019-05223-6","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T10:12:10Z","timestamp":1576491130000},"page":"1223-1232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus"],"prefix":"10.1007","volume":"47","author":[{"given":"Narges","family":"Gholizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirnader","family":"Emami Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadiseh","family":"Mohammadpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Tavakol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3869-7256","authenticated-orcid":false,"given":"Nafiseh","family":"Sheykhbahaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"key":"5223_CR1","first-page":"57","volume":"7","author":"S Najafi","year":"2015","unstructured":"Najafi S, Gholizadeh N, Manifar S, Rajabzadeh S, Kharazi FM (2015) Salivary antioxidant level in oral squamous cell carcinoma. Iran J Blood Cancer 7:57\u201360","journal-title":"Iran J Blood Cancer"},{"key":"5223_CR2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.22317\/jcms.v5i2.572","volume":"5","author":"N Gholizadeh","year":"2019","unstructured":"Gholizadeh N, Razavi HE, Haftkhani GJ, Sheykhbahaei N (2019) Predictive factors of survival rate in oral squamous cell carcinoma: a retrospective study in Iran. J Contemp Med Sci 5:101\u2013105","journal-title":"J Contemp Med Sci"},{"key":"5223_CR3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.5005\/jp-journals-10024-1914","volume":"17","author":"F Agha-Hosseini","year":"2016","unstructured":"Agha-Hosseini F, Sheykhbahaei N, SadrZadeh-Afshar M (2016) Evaluation of potential risk factors that contribute to malignant transformation of oral lichen planus: a literature review. J Contemp Dent Pract 17:692\u2013701","journal-title":"J Contemp Dent Pract"},{"key":"5223_CR4","first-page":"51","volume":"7","author":"P Rupakar","year":"2016","unstructured":"Rupakar P, Kureshi A, Balar A, Khatri M, Parmar M, Pujara P et al (2016) Estimation of serum B2-microglobulin in oral precancerous lesions and oral squamous cell carcinoma. Natl J Integr Res Med 7:51\u201355","journal-title":"Natl J Integr Res Med"},{"key":"5223_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.oraloncology.2017.03.012","volume":"68","author":"SMH Aghbari","year":"2017","unstructured":"Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS et al (2017) Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data. Oral Oncol 68:92\u2013102","journal-title":"Oral Oncol"},{"key":"5223_CR6","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.4317\/medoral.20205","volume":"19","author":"I Van der Waal","year":"2014","unstructured":"Van der Waal I (2014) Oral potentially malignant disorders: is malignant transformation predictable and preventable? Med Oral Patol Oral Cir Bucal 19:e386","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"5223_CR7","first-page":"136","volume":"10","author":"N Gholizadeh","year":"2015","unstructured":"Gholizadeh N, Poorfar HK, TaghaviZenouz A, Vatandoost M, Mehdipour M (2015) Comparison of serum autoantibodies to desmogleins I, III in patients with oral lichen planus and healthy controls. Iran J Pathol 10:136","journal-title":"Iran J Pathol"},{"key":"5223_CR8","first-page":"41","volume":"11","author":"SS Kumar","year":"2018","unstructured":"Kumar SS, Zain RB (2018) Aetiology and risk factors for oral cancer\u2013a brief overview. Ann Dent Univ Malaya 11:41\u201350","journal-title":"Ann Dent Univ Malaya"},{"key":"5223_CR9","doi-asserted-by":"publisher","first-page":"a011254","DOI":"10.1101\/cshperspect.a011254","volume":"4","author":"DK Morrison","year":"2012","unstructured":"Morrison DK (2012) MAP kinase pathways. Cold Spring Harb Perspect Biol 4:a011254","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5223_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ceca.2018.03.002","volume":"72","author":"C Pierro","year":"2018","unstructured":"Pierro C, Zhang X, Kankeu C, Trebak M, Bootman MD, Roderick HL (2018) Oncogenic KRAS suppresses store-operated Ca2+\u2009entry and ICRAC through ERK pathway-dependent remodelling of STIM expression in colorectal cancer cell lines. Cell Calcium 72:70\u201380","journal-title":"Cell Calcium"},{"key":"5223_CR11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.ygyno.2006.05.029","volume":"103","author":"D Mayr","year":"2006","unstructured":"Mayr D, Hirschmann A, L\u00f6hrs U, Diebold J (2006) KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants. Gynecol Oncol 103:883\u2013887","journal-title":"Gynecol Oncol"},{"key":"5223_CR12","first-page":"2382","volume":"7","author":"X Cui","year":"2014","unstructured":"Cui X, Li S, Li T, Pang X, Zhang S, Jin J et al (2014) Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 7:2382","journal-title":"Int J Clin Exp Pathol"},{"key":"5223_CR13","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/labinvest.2010.79","volume":"90","author":"G Regalo","year":"2010","unstructured":"Regalo G, Resende C, Wen X, Gomes B, Dur\u00e3es C, Seruca R et al (2010) C\/EBP\u03b1 expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis. Lab Investig 90:1132","journal-title":"Lab Investig"},{"key":"5223_CR14","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.3390\/cancers7030863","volume":"7","author":"V Pipan","year":"2015","unstructured":"Pipan V, Zorc M, Kunej T (2015) MicroRNA polymorphisms in cancer: a literature analysis. Cancers (Basel) 7:1806\u20131814","journal-title":"Cancers (Basel)"},{"key":"5223_CR15","doi-asserted-by":"publisher","first-page":"11641","DOI":"10.18632\/oncotarget.14264","volume":"8","author":"R Bayraktar","year":"2017","unstructured":"Bayraktar R, Pichler M, Kanlikilicer P, Ivan C, Bayraktar E, Kahraman N et al (2017) MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Oncotarget 8:11641","journal-title":"Oncotarget"},{"key":"5223_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.biopha.2016.02.043","volume":"80","author":"J Wang","year":"2016","unstructured":"Wang J, Luo H, Xiao Y, Wang L (2016) miR-125b inhibits keratinocyte proliferation and promotes keratinocyte apoptosis in oral lichen planus by targeting MMP-2 expression through PI3 K\/Akt\/mTOR pathway. Biomed Pharmacother 80:373\u2013380","journal-title":"Biomed Pharmacother"},{"key":"5223_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/jop.12785","volume":"48","author":"SM Aghbari","year":"2019","unstructured":"Aghbari SM, Zayed SO, Shaker OG, Abushouk AI (2019) Evaluating the role of tissue micro RNA-27b as a diagnostic marker for oral lichen planus and possible correlation with CD 8. J Oral Pathol Med 48:68\u201373","journal-title":"J Oral Pathol Med"},{"key":"5223_CR18","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00784-017-2252-6","volume":"22","author":"SMH Aghbari","year":"2018","unstructured":"Aghbari SMH, Abushouk AI, Shakir OG, Zayed SO, Attia A (2018) Correlation between tissue expression of microRNA-137 and CD8 in oral lichen planus. Clin Oral Investig 22:1463\u20131467","journal-title":"Clin Oral Investig"},{"key":"5223_CR19","first-page":"316","volume":"14","author":"F Ahmadi-Motamayel","year":"2017","unstructured":"Ahmadi-Motamayel F, Bayat Z, Hajilooi M, Shahryar-Hesami S, Mahdavinezhad A, Samie L et al (2017) Evaluation of the miRNA-146a and miRNA-155 expression levels in patients with oral lichen planus. Iran J Immunol 14:316\u2013324","journal-title":"Iran J Immunol"},{"key":"5223_CR20","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s00784-017-2091-5","volume":"21","author":"NA Ghallab","year":"2017","unstructured":"Ghallab NA, Kasem RF, El-Ghani SFA, Shaker OG (2017) Gene expression of miRNA-138 and cyclin D1 in oral lichen planus. Clin Oral Investig 21:2481\u20132491","journal-title":"Clin Oral Investig"},{"key":"5223_CR21","first-page":"575","volume":"17","author":"Y Tao","year":"2019","unstructured":"Tao Y, Ai R, Hao Y, Jiang L, Dan H, Ji N et al (2019) Role of miR-155 in immune regulation and its relevance in oral lichen planus. Exp Ther Med 17:575\u2013586","journal-title":"Exp Ther Med"},{"key":"5223_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1600-0714.2011.01084.x","volume":"41","author":"K Danielsson","year":"2012","unstructured":"Danielsson K, Wahlin Y-B, Gu X, Boldrup L, Nylander K (2012) Altered expression of miR-21, miR-125b, and miR-203 indicates a role for these microRNAs in oral lichen planus. J Oral Pathol Med 41:90\u201395","journal-title":"J Oral Pathol Med"},{"key":"5223_CR23","first-page":"994","volume":"19","author":"G Wang","year":"2019","unstructured":"Wang G, Zheng X, Zheng Y, Cao R, Zhang M, Sun Y et al (2019) Construction and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional genes in heart failure. Mol Med Rep 19:994\u20131003","journal-title":"Mol Med Rep"},{"key":"5223_CR24","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1515\/biol-2017-0054","volume":"12","author":"J Cheng","year":"2017","unstructured":"Cheng J, Chen J, Wang Z, Yu D, Zu Y (2017) The functional role of microRNAs in laryngeal carcinoma. Open Life Sci 12:460\u2013464","journal-title":"Open Life Sci"},{"key":"5223_CR25","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00432-013-1469-2","volume":"139","author":"L Ayaz","year":"2013","unstructured":"Ayaz L, G\u00f6r\u00fcr A, Yaro\u011flu HY, \u00d6zcan C, Tamer L (2013) Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol 139:1499\u20131506","journal-title":"J Cancer Res Clin Oncol"},{"key":"5223_CR26","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1177\/039463201002300427","volume":"23","author":"L Scapoli","year":"2010","unstructured":"Scapoli L, Palmieri A, Muzio LL, Pezzetti F, Rubini C, Girardi A et al (2010) MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol 23:1229\u20131234","journal-title":"Int J Immunopathol Pharmacol"},{"key":"5223_CR27","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00018-010-0316-8","volume":"67","author":"J Lu","year":"2010","unstructured":"Lu J, Zhao J, Liu K, Zhao J, Yang H, Huang Y et al (2010) MAPK\/ERK1\/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma. Cell Mol Life Sci 67:2091\u20132106","journal-title":"Cell Mol Life Sci"},{"key":"5223_CR28","first-page":"549","volume":"31","author":"K Sasaki","year":"2011","unstructured":"Sasaki K, Hitora T, Nakamura O, Kono R, Yamamoto T (2011) The role of MAPK pathway in bone and soft tissue tumors. Anticancer Res 31:549\u2013553","journal-title":"Anticancer Res"},{"key":"5223_CR29","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/onc.2013.13","volume":"33","author":"H Nakanishi","year":"2014","unstructured":"Nakanishi H, Taccioli C, Palatini J, Fernandez-Cymering C, Cui R, Kim T et al (2014) Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway. Oncogene 33:702","journal-title":"Oncogene"},{"key":"5223_CR30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3892\/or.2015.4344","volume":"35","author":"X Yang","year":"2016","unstructured":"Yang X, Wu X (2016) miRNA expression profile of vulvar squamous cell carcinoma and identification of the oncogenic role of miR-590-5p. Oncol Rep 35:398\u2013408","journal-title":"Oncol Rep"},{"key":"5223_CR31","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.3892\/or.2016.4718","volume":"35","author":"C Ma","year":"2016","unstructured":"Ma C, Zhan C, Yuan H, Cui Y, Zhang Z (2016) MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma. Oncol Rep 35:3257\u20133264","journal-title":"Oncol Rep"},{"key":"5223_CR32","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ebiom.2015.05.011","volume":"2","author":"MS Stark","year":"2015","unstructured":"Stark MS, Klein K, Weide B, Haydu LE, Pflugfelder A, Tang YH et al (2015) The prognostic and predictive value of melanoma-related microRNAs using tissue and serum: a microRNA expression analysis. EBioMedicine 2:671\u2013680","journal-title":"EBioMedicine"},{"key":"5223_CR33","doi-asserted-by":"publisher","first-page":"49677","DOI":"10.18632\/oncotarget.10109","volume":"7","author":"MS Stark","year":"2016","unstructured":"Stark MS, Tom LN, Boyle GM, Bonazzi VF, Soyer HP, Herington AC et al (2016) The \u2018Melanoma-enriched\u2019microRNA miR-4731-5p acts as a tumour suppressor. Oncotarget 7:49677","journal-title":"Oncotarget"},{"key":"5223_CR34","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1038\/mtna.2015.5","volume":"4","author":"M Hiraki","year":"2015","unstructured":"Hiraki M, Nishimura J, Takahashi H, Wu X, Takahashi Y, Miyo M et al (2015) Concurrent targeting of KRAS and AKT by MiR-4689 is a novel treatment against mutant KRAS colorectal cancer. Mol Ther-Nucleic Acids 4:e231","journal-title":"Mol Ther-Nucleic Acids"},{"key":"5223_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ygeno.2013.06.006","volume":"103","author":"Z Fan","year":"2014","unstructured":"Fan Z, Chen X, Chen R (2014) Transcriptome-wide analysis of TDP-43 binding small RNAs identifies miR-NID1 (miR-8485), a novel miRNA that represses NRXN1 expression. Genomics 103:76\u201382","journal-title":"Genomics"},{"key":"5223_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.msard.2018.04.005","volume":"22","author":"Y Kattimani","year":"2018","unstructured":"Kattimani Y, Veerappa AM (2018) Dysregulation of NRXN1 by mutant MIR8485 leads to calcium overload in pre-synapses inducing neurodegeneration in Multiple sclerosis. Mult Scler Relat Disord 22:153\u2013156","journal-title":"Mult Scler Relat Disord"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-05223-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-019-05223-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-05223-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T15:16:29Z","timestamp":1665242189000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-019-05223-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5223"],"URL":"https:\/\/doi.org\/10.1007\/s11033-019-05223-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]},"assertion":[{"value":"25 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}